Cargando…
Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?
Autores principales: | Ahmad, Akram, Khan, Muhammad Umair, Patel, Isha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326966/ https://www.ncbi.nlm.nih.gov/pubmed/25710043 http://dx.doi.org/10.4103/2279-042X.150043 |
Ejemplares similares
-
Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007) -
Open access: What price affordability?
por: Poynder, Richard
Publicado: (2014) -
Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe
por: Carl, David L, et al.
Publicado: (2021) -
Antiepileptic Drug Prices, Availability and Affordability in a Resource-Limited Setting
por: Singh, Karan, et al.
Publicado: (2020) -
Ensuring Access to Affordable Drug Coverage in Medicare
por: Antos, Joseph R.
Publicado: (2005)